Your browser doesn't support javascript.
loading
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.
Schavgoulidze, Anaïs; Perrot, Aurore; Cazaubiel, Titouan; Leleu, Xavier; Montes, Lydia; Jacquet, Caroline; Belhadj, Karim; Brechignac, Sabine; Frenzel, Laurent; Chalopin, Thomas; Rey, Philippe; Schiano de Collela, Jean-Marc; Dib, Mamoun; Caillot, Denis; Macro, Margaret; Fontan, Jean; Buisson, Laure; Pavageau, Luka; Roussel, Murielle; Manier, Salomon; Mohty, Mohamad; Martinet, Ludovic; Avet-Loiseau, Hervé; Corre, Jill.
Afiliación
  • Schavgoulidze A; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.
  • Perrot A; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.
  • Cazaubiel T; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.
  • Leleu X; Hematology Department, IUCT-Oncopole, Toulouse, France.
  • Montes L; Hematology Department, University Hospital, Bordeaux, France.
  • Jacquet C; Hematology Department, University Hospital, Poitiers, France.
  • Belhadj K; Hematology Department, University Hospital, Amiens, France.
  • Brechignac S; Hematology Department, University Hospital, Nancy, France.
  • Frenzel L; Hematology Department, University Hospital, Créteil, France.
  • Chalopin T; Hematology Department, University Hospital, Bobigny, France.
  • Rey P; Hematology Department, Necker University Hospital, Paris, France.
  • Schiano de Collela JM; Hematology Department, University Hospital, Tours, France.
  • Dib M; Hematology Department, Centre Léon Bérard, Lyon, France.
  • Caillot D; Hematology Department, Institut Paoli Calmettes, Marseille, France.
  • Macro M; Hematology Department, University Hospital, Angers, France.
  • Fontan J; Hematology Department, Institut de Cancérologie de Bourgogne, Dijon, France.
  • Buisson L; Hematology Department, University Hospital, Caen, France.
  • Pavageau L; Hematology Department, University Hospital, Besançon, France.
  • Roussel M; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.
  • Manier S; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.
  • Mohty M; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.
  • Martinet L; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.
  • Avet-Loiseau H; Hematology Department, University Hospital, Limoges, France.
  • Corre J; Hematology Department, University Hospital, Lille, France.
Blood Cancer J ; 13(1): 160, 2023 10 26.
Article en En | MEDLINE | ID: mdl-37880285
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos